Mylan has been appointed as the exclusive distributor of Sovaldi (sofosbuvir 400mg tablets) and Harvoni Read the full story

Mylan Laboratories is expanding its hepatitis C licensing agreement with Gilead Sciences to include the non-exclusive rights to manufacture and distribute the investigational NS5A inhibitor GS-5816 Read the full story

EnvisionRx announced a partnership with Gilead Sciences to provide availability to HCV infection treatments Sovaldi and Harvoni Read the full story

The term 'top pharma' can relate to the top pharmaceutical companies or the top 10 or 50... Read the full story

Cancer Genetics and Gilead Sciences, a big pharma company, are now biopharma partners where Cancer Genetics is providing clinical trial services and molecular profiling of chronic lymphocytic leukemia patients. Read the full story

Gilead and Teva Pharmaceuticals, two top big pharma companies, have reached a settlement agreement in principle to settle the ongoing patent litigation concerning the patents protecting Viread (tenofovir disoproxil fumarate). Read the full story

Gilead Sciences is on the lookout for pharma partners for it's HIV business and has spent $1.2 billion in two years to buy blood cancer drugs. Read the full story

This report provides all the information you require to better understand Gilead Sciences and its partnering interests and activities over the past seven years. Read the full story

Gilead Sciences, a big pharma company has inked a pharma partnering deal with AnaptysBio to develop antibody therapeutics Read the full story

Adimab and Gilead Sciences, a top big pharma company  have initiated a pharma partnering research collaboration to identify therapeutic antibodies against two targets selected by Gilead Read the full story